These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21458987)

  • 41. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
    Shweiki D; Itin A; Soffer D; Keshet E
    Nature; 1992 Oct; 359(6398):843-5. PubMed ID: 1279431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay.
    Knizetova P; Ehrmann J; Hlobilkova A; Vancova I; Kalita O; Kolar Z; Bartek J
    Cell Cycle; 2008 Aug; 7(16):2553-61. PubMed ID: 18719373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.
    Fisher T; Galanti G; Lavie G; Jacob-Hirsch J; Kventsel I; Zeligson S; Winkler R; Simon AJ; Amariglio N; Rechavi G; Toren A
    Cancer J; 2007; 13(5):335-44. PubMed ID: 17921733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release.
    Di Vito C; Navone SE; Marfia G; Abdel Hadi L; Mancuso ME; Pecci A; Crisà FM; Berno V; Rampini P; Campanella R; Riboni L
    Platelets; 2017 Sep; 28(6):585-594. PubMed ID: 27897101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma.
    Fujita Y; Mimata H; Nasu N; Nomura T; Nomura Y; Nakagawa M
    Int J Urol; 2002 Jun; 9(6):285-95. PubMed ID: 12110091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
    Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
    Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion.
    Keleg S; Kayed H; Jiang X; Penzel R; Giese T; Büchler MW; Friess H; Kleeff J
    Int J Cancer; 2007 Jul; 121(1):21-32. PubMed ID: 17290391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.
    Feldkamp MM; Lau N; Rak J; Kerbel RS; Guha A
    Int J Cancer; 1999 Mar; 81(1):118-24. PubMed ID: 10077162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic-Angiogenic Pathway.
    D'Amico AG; Maugeri G; Vanella L; Consoli V; Sorrenti V; Bruno F; Federico C; Fallica AN; Pittalà V; D'Agata V
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adrenomedullin increases the expression of calcitonin-like receptor and receptor activity modifying protein 2 mRNA in human microvascular endothelial cells.
    Schwarz N; Renshaw D; Kapas S; Hinson JP
    J Endocrinol; 2006 Aug; 190(2):505-14. PubMed ID: 16899583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
    Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
    Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme.
    Debinski W; Slagle-Webb B; Achen MG; Stacker SA; Tulchinsky E; Gillespie GY; Gibo DM
    Mol Med; 2001 Sep; 7(9):598-608. PubMed ID: 11778649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.
    Reddy PS; Umesh S; Thota B; Tandon A; Pandey P; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
    Cancer Biol Ther; 2008 May; 7(5):663-8. PubMed ID: 18728403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
    Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
    Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y; Zhang QG; Wang XH
    Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-1β promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production.
    Sun W; Depping R; Jelkmann W
    Cell Death Dis; 2014 Jan; 5(1):e1020. PubMed ID: 24457964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
    Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
    Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
    Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.